Abstract:Abstract Background Drug repositioning, the strategy of unveiling novel targets of existing drugs could reduce costs and accelerate the pace of drug development. To elucidate the novel molecular mechanism of known drugs, considering the long time and high cost of experimental determination, the efficient and feasible computational methods to predict the potential associations between drugs and targets are of great aid. Methods A novel calculation model for drug-target interaction (DTI) prediction based on network representation learning and convolutional neural networks, called DLDTI, was generated. The proposed approach simultaneously fused the topology of complex networks and diverse information from heterogeneous data sources, and coped with the noisy, incomplete, and high-dimensional nature of large-scale biological data by learning the low-dimensional and rich depth features of drugs and proteins. The low-dimensional feature vectors were used to train DLDTI to obtain the optimal mapping space and to infer new DTIs by ranking candidates according to their proximity to the optimal mapping space. More specifically, based on the results from the DLDTI, we experimentally validated the predicted targets of tetramethylpyrazine (TMPZ) on atherosclerosis progression in vivo. Results The experimental results showed that the DLDTI model achieved promising performance under fivefold cross-validations with AUC values of 0.9172, which was higher than the methods using different classifiers or different feature combination methods mentioned in this paper. For the validation study of TMPZ on atherosclerosis, a total of 288 targets were identified and 190 of them were involved in platelet activation. The pathway analysis indicated signaling pathways, namely PI3K/Akt, cAMP and calcium pathways might be the potential targets. Effects and molecular mechanism of TMPZ on atherosclerosis were experimentally confirmed in animal models. Conclusions DLDTI model can serve as a useful tool to provide promising DTI candidates for experimental validation. Based on the predicted results of DLDTI model, we found TMPZ could attenuate atherosclerosis by inhibiting signal transductions in platelets. The source code and datasets explored in this work are available at https://github.com/CUMTzackGit/DLDTI .

A Protein-Context Enhanced Master Slave Framework for Zero-Shot Drug Target Interaction Prediction

A uniﬁed framework for drug-target interaction prediction by semantic-guided meta-path method

A Robust Drug-Target Interaction Prediction Framework with Capsule Network and Transfer Learning

DLDTI: a learning-based framework for drug-target interaction identification using neural networks and network representation

A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network

Versatile Framework for Drug-Target Interaction Prediction by Considering Domain-Specific Features

Integrating multi-scale neighbouring topologies and cross-modal similarities for drug–protein interaction prediction

MocFormer: A Two-Stage Pre-training-Driven Transformer for Drug–Target Interactions Prediction

SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction

PADME: A Deep Learning-based Framework for Drug-Target Interaction Prediction

ZeroBind: a protein-specific zero-shot predictor with subgraph matching for drug-target interactions

Efficient Deep Model Ensemble Framework for Drug-Target Interaction Prediction

LDS-CNN: a deep learning framework for drug-target interactions prediction based on large-scale drug screening

Drug3D-DTI: Improved Drug-target Interaction Prediction by Incorporating Spatial Information of Small Molecules

CHL-DTI: A Novel High–Low Order Information Convergence Framework for Effective Drug–Target Interaction Prediction

In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences

DTIAM: A unified framework for predicting drug-target interactions, binding affinities and activation/inhibition mechanisms

DTI-CDF: a cascade deep forest model towards the prediction of drug-target interactions based on hybrid features

MolTrans: Molecular Interaction Transformer for Drug Target Interaction Prediction

MIN: Multi-channel Interaction Network for Drug-Target Interaction with Protein Distillation

Drug-target interaction prediction with collaborative contrastive learning and adaptive self-paced sampling strategy